Fundamental & Clinical Pharmacology Virtual Issues
Fundamental & Clinical Pharmacology
TopEditors' choice in Cardiovascular Pharmacology April 2008
The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance
A. L. Catapano
Sympathetic control of short-term heart rate variability and its pharmacological modulation
Jean-Luc Elghozi,
Claude Julien
Melatonin counteracts the loss of agonist-evoked contraction of aortic rings induced by incubation
Isabelle Lartaud,
Sebastien Faure,
Aurore Tabellion,
Angela Resende,
Sophie Nadaud,
Denyse Bagrel,
Christine Capdeville-Atkinson,
Jeffrey Atkinson
Clinical Pharmacology in the Geriatric Patient
Sarah Hilmer,
Andrew McLachlan,
David Le Couteur
Rationale, Design and Methods of the OSCAR Study: Observational Study on Cognitive Function and Systolic Blood Pressure Reduction in Hypertensive Patients.
Atul Pathak,
Olivier Hanon,
Laurence Negre-Pages,
Franck Sevenier
Blood pressure lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists. An overview of randomized controlled studies.
Faiez Zannad,
Renaud Fay
Understanding the estrogen action in experimental and clinical atherosclerosis.
J.F. Arnal,
V. Douin-Echinard,
L. Brouchet,
F. Tremollieres,
H. Laurell,
F. Lenfant,
A.P. Gadeau,
J.C. Guery,
P. Gourdy
Clinical methods for the evaluaation of endothelial function - a focus on resistance arteries
Adeline Paris,
Catherine Cornu,
Pascal Antiquier,
Patrick Maison,
Anca Radauceanu,
Christian Brandt,
Muriel Salvat-Melis,
Marc Hommel,
Jean-Luc Cracowski
Early pharmacological preconditioning by erythropoietin medicated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart
M Joyeux-Faure,
A Ramond,
P.C. Béguin,
E Belaïdi,
D Godin-Ribuot,
C Ribuot
Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments
Jean-Pierre Boissel,
Francois Gueyffier,
Florent Boutitie,
Stuart Pocock,
Robert Fagard
Erythropoietin and myocardial protection: whats new?
M Joyeux-Faure,
D Godin-Ribuot,
C Ribuot
Vascular and renal actions of Brain Natriuretic Peptide in man: physiology and pharmacology
Peter De Leeuw,
Alphons Houben,
Kim van der Zander
Effects of melatonin and caffeic acid phenethyl ester on testicular injury induced by myocardial ischenia/reperfusion in rats
M Esrefoglu,
Mehmet Gul,
Hakan Parlakpinar,
Ahmet Acet
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
Michael Schachter
G protein- coupled receptors: a count of 1001 conformations
I Van Liefde,
Georges Vauquelin
